Immunomodulatory functions of murine CR1/2

被引:28
作者
Prechl, J [1 ]
Erdei, A [1 ]
机构
[1] Eotvos Lorand Univ, Dept Immunol, Hungarian Acad Sci, Res Grp, God, Hungary
来源
IMMUNOPHARMACOLOGY | 2000年 / 49卷 / 1-2期
关键词
murine CR1/2; complement activation; B cell response; receptor cross-talk;
D O I
10.1016/S0162-3109(00)80297-0
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
C3-fragments generated upon complement activation play an important role in the formation and regulation of immune responses. Receptors interacting with various activation fragments of this versatile complement component are expressed on a wide variety of cell types, such as lymphocytes, macrophages, dendritic cells, follicular dendritic cells, granulocytes, erythrocytes, consequently C3-products may influence several biological functions at different sites of the body, where complement activation takes place. In the last decade, genes, protein structure and functions played by murine complement receptors CR1 and CR2 (mCR1/2) have been deciphered. In this review, we wish to relate these properties, and fit it into the context of events following in vivo complement activation. We separately address the roles played by murine mCR1/2 as BCR coreceptor and as BCR independent structure, and propose a mchanism for the utilization of antigen-C3d conjugates bound on B cells. Finally, we raise some of the questions that remain to be elucidated in order to get a more precise picture of the functions of mCR1/2. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:117 / 124
页数:8
相关论文
共 59 条
[1]   Disruption of the Cr2 locus results in a reduction in B-1a cells and in an impaired B cell response to T-dependent antigen [J].
Ahearn, JM ;
Fischer, MB ;
Croix, D ;
Goerg, S ;
Ma, MH ;
Xia, JR ;
Zhou, XN ;
Howard, RG ;
Rothstein, TL ;
Carroll, MC .
IMMUNITY, 1996, 4 (03) :251-262
[2]  
ARVIEUX J, 1988, IMMUNOLOGY, V65, P229
[3]   Regulation of B cell growth and differentiation via CD21 and CD40 [J].
Axcrona, K ;
Gray, D ;
Leanderson, T .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1996, 26 (09) :2203-2207
[4]  
Baiu DC, 1999, J IMMUNOL, V162, P3125
[5]  
Boackle SA, 1998, J IMMUNOL, V161, P6537
[6]   CD21 augments antigen presentation in immune individuals [J].
Boackle, SA ;
Holers, VM ;
Karp, DR .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (01) :122-129
[7]  
Carroll M, 1999, CURR TOP MICROBIOL, V246, P63
[8]   C3d of complement as a molecular adjuvant: Bridging innate and acquired immunity [J].
Dempsey, PW ;
Allison, MED ;
Akkaraju, S ;
Goodnow, CC ;
Fearon, DT .
SCIENCE, 1996, 271 (5247) :348-350
[9]   Complement factors and their receptors [J].
Ember, JA ;
Hugli, TE .
IMMUNOPHARMACOLOGY, 1997, 38 (1-2) :3-15
[10]   THE ACTION OF HUMAN C-3 IN SOLUBLE OR CROSS-LINKED FORM WITH RESTING AND ACTIVATED MURINE LYMPHOCYTES-B [J].
ERDEI, A ;
MELCHERS, F ;
SCHULZ, T ;
DIERICH, M .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1985, 15 (02) :184-188